Evaluation of the Antitumor Effects of C-Myc-Max Heterodimerization Inhibitor 100258-F4 in Ovarian Cancer Cells
Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-014-0226-x
Full Text
Open PDFAbstract
Available in full text
Date
August 21, 2014
Authors
Publisher
Springer Science and Business Media LLC